(Juan Gaertner/Science Photo Library/Getty Images) Scientists looking to combat Alzheimer's disease may have found two ...

Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process ...

Alzheimer's disease affects hundreds of thousands of people across the UK, here is what we know about the condition ...

CBS news correspondent Natalie Morales talks about mother-in-law Kay Rhodes's diagnosis of early-onset Alzheimer's disease ...

What is Alzheimer’s disease? The symptoms and causes explained after Jon Snow diagnosis - Alzheimer's disease, a physical ...

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has expanded its scientific network in Alzheimer’s and Parkinson’s disease, adding ...

An international collaboration of genetic researchers has identified more than 90 genetic regions associated with the risk of ...

More than 7 million Americans are living with Alzheimer’s disease in the U.S. right now, but only about 16% say they know ...

Researchers created Compound 10 to block GRK2 enzyme aggregation and protect mitochondria in Alzheimer's disease.

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. The recent FDA approval of Eli Lilly’s new immunotherapy ...

A new study discovers a critical microglial cell transition that determines whether Alzheimer’s pathology causes dementia.

While the Tennessee chapter of the Alzheimer's Association has long raised awareness and funding for treatments and a cure, ...